CMS Issues Request for Information on Electronic Prescribing of Controlled Substances; President Trump Signed Executive Orders on Drug Pricing; AMCP Submits Comments on Medicaid Drug Rebate Program Proposed Rule; House of Representatives Holds COVID-19 Vaccine and Coronavirus Response Hearings.
CMS Issues Proposed Rule Updating the Medicaid Drug Rebate Program; SAMHSA Publishes Final Rule Amending Substance Use Disorder Treatment Records Privacy; AMCP Joins Pharmacy Stakeholder Letter on Vaccine Administration; AMCP Signs Joint Comment Letter on Pharmacy Telehealth in Medicare.
Sponsored webinar that reviewed the recommended tools for asthma assessment and management, pharmacotherapy considerations to improve management and control and the GINA guidance for COVID-19 and asthma.
Sponsored webinar that highlighted a new frontier of cannabis-related advocacy—state mandated health insurance coverage for non-FDA-approved cannabis products.